Multiple myeloma patients more vulnerable to 'financial toxicity' due to expensive, longer courses of treatments

Even patients with health insurance who have multiple myeloma may be vulnerable to “financial toxicity” because of the higher use of novel therapeutics and extended duration of myeloma treatment, researchers report.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1OzyNxX